drugset / Trial / NCT02222974
Single Increasing Dose Tolerance Study in Healthy Male Volunteers of BIIR 561 CL
RandomizedParallel-groupSingle-blindTreatment
Summary
The objective of the study is to obtain information about safety, tolerability and pharmacokinetics of BIIR 561 CL after single intravenous administration of increasing doses in healthy male volunteers
Timeline
- Start
- 1999-01
- Primary completion
- 1999-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IRAMPANEL | Small molecule | 1 mg | Intravenous |
| Subject | IRAMPANEL | Small molecule | 175 mg | Intravenous |
Indications
No indication recorded.